Activation or suppression of NFκB by HPK1 determines sensitivity to activation-induced cell death

被引:63
作者
Brenner, D
Golks, A
Kiefer, F
Krammer, PH
Arnold, R
机构
[1] German Canc Res Ctr, Tumor Immunol Program, D-69112 Heidelberg, Germany
[2] Max Planck Inst Mol Biomed, Munster, Germany
关键词
AICD; apoptosis; IKK; signaling; TCR;
D O I
10.1038/sj.emboj.7600894
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Restimulation of the T-cell receptor (TCR) in activated T cells induces CD95 (Fas/Apo-1)-mediated activation-induced cell death (AICD). The TCR-proximal mechanisms leading to AICD are elusive. Here we characterize hematopoietic progenitor kinase 1 (HPK1) as a differentially regulated TCR-proximal signaling protein involved in AICD of primary T cells. We show that HPK1 is a functional component of the endogenous I kappa B kinase (IKK) complex and is crucial for TCR-mediated NF kappa B activation. While full-length HPK1 enhances IKK beta phosphorylation, siRNA-mediated knockdown of HPK1 blunts TCR-mediated NF kappa B activation and increases cell death. We also demonstrate proteolytic processing of HPK1 into HPK1-C, specifically in AICD-sensitive primary T cells. The cleavage product HPK1-C sequesters the inactive IKK complex and suppresses NF kappa B upon TCR restimulation by binding to IKK alpha and IKK beta. T cells of HPK1-C transgenic mice are sensitized towards TCR-mediated AICD. Consequently, preventing HPK1-C generation in primary T cells by siRNA-mediated knockdown results in decreased AICD. Thus, these results show a novel mechanism of sensitization of T lymphocytes towards AICD by suppression of NF kappa B, and propose that HPK1 is a life/death switch in T lymphocytes.
引用
收藏
页码:4279 / 4290
页数:12
相关论文
共 58 条
  • [31] HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1
    Liou, J
    Kiefer, F
    Dang, A
    Hashimoto, A
    Cobb, MH
    Kurosaki, T
    Weiss, A
    [J]. IMMUNITY, 2000, 12 (04) : 399 - 408
  • [32] A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
    Lissy, NA
    Davis, PK
    Irwin, M
    Kaelin, WG
    Dowdy, SF
    [J]. NATURE, 2000, 407 (6804) : 642 - 645
  • [33] The adaptor protein Gads (Grb2-related adaptor downstream of Shc) is implicated in coupling hemopoietic progenitor kinase-1 to the activated TCR
    Liu, SK
    Smith, CA
    Arnold, R
    Kiefer, F
    McGlade, CJ
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (03) : 1417 - 1426
  • [34] A novel ubiquitin-like domain in IκB kinase β is required for functional activity of the kinase
    May, MJ
    Larsen, SE
    Shim, JH
    Madge, LA
    Ghosh, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) : 45528 - 45539
  • [35] Effector CD4+ T cells generate intermediate caspase activity and cleavage of caspase-8 substrates
    Misra, RS
    Jelley-Gibbs, DM
    Russell, JQ
    Huston, G
    Swain, SL
    Budd, RC
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (07) : 3999 - 4009
  • [36] Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase
    Nemoto, S
    DiDonato, JA
    Lin, AN
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) : 7336 - 7343
  • [37] Noel PJ, 1996, J IMMUNOL, V157, P636
  • [38] The CD95(APO-1/Fas) DISC and beyond
    Peter, ME
    Krammer, PH
    [J]. CELL DEATH AND DIFFERENTIATION, 2003, 10 (01) : 26 - 35
  • [39] Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex
    Peter, ME
    Kischkel, FC
    Scheuerpflug, CG
    Medema, JP
    Debatin, KM
    Krammer, PH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) : 1207 - 1212
  • [40] Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species
    Pham, CG
    Bubici, C
    Zazzeroni, F
    Papa, S
    Jones, J
    Alvarez, K
    Jayawardena, S
    De Smaele, E
    Cong, R
    Beaumont, C
    Torti, FM
    Torti, SV
    Franzoso, G
    [J]. CELL, 2004, 119 (04) : 529 - 542